Regulations, Legislation & Enforcement

©Getty Images - sarayut

Kratom group says CBD regulatory experience offers some lessons

By Hank Schultz

The history of the CBD trade in the US provides a peek into the strategy that kratom proponents may pursue with the goal of a legal trade in the botanical without regulatory impediments, an executive in an advocacy group says.

NPA’s Fabricant on CBD, NDI-related import alerts, and banned stimulants

NPA’s Fabricant on CBD, NDI-related import alerts, and banned stimulants

By Stephen Daniells

Efforts to move the needle on hemp-CBD at the Federal level are slow, and upcoming exits of key personnel at FDA are unlikely to affect progress much, says NPA’s Dr Daniel Fabricant. “In some ways I think FDA likes the status quo,” he tells NutraIngredients-USA.

Follow us

Products

View more

Webinars